诺和诺德宣布裁员9000人

Group 1 - The core point of the article is that Danish pharmaceutical giant Novo Nordisk announced a global restructuring plan that will involve laying off approximately 9,000 employees, aiming to save 8 billion Danish kroner (approximately 1.26 billion USD) annually [1] Group 2 - The restructuring is part of a broader strategy to enhance operational efficiency and reduce costs within the company [1] - The decision reflects ongoing challenges in the pharmaceutical industry, including pressures on pricing and competition [1] - The layoffs are expected to impact various departments and regions, indicating a significant shift in the company's workforce strategy [1]